Advanced search×

Hormone treatment of the sexual offender.

F L GOLLA and R S HODGE

Lancet 1(6563):1006 (1949) PMID 18145096

Version: za2963e q8zac q8zba q8zcf q8zdb q8zec q8zf2 q8zg9
Buy PDF

Similar articles you may find interesting…

  1. Androgen therapy in women, beyond libido.
    S R Davis

    Climacteric (2013) PMID 23647457

    ABSTRACT Objective The aim of this review was to summarize the literature regarding the potential role of testosterone therapy for women. Methods The author conducted a search of the literature using Medline (Ovid, 1946-present) and PubMed (1966-2013) for English-language studies tha...
    Buy PDF
  2. Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Brea...
    Edith A Perez, Amylou C Dueck, and Monica M Reinholz

    J Clin Oncol (2013) PMID 23650412

    We investigated the association between tumor PTEN protein expression and disease-free survival (DFS) of patients randomly assigned to receive chemotherapy alone (arm A) or chemotherapy with sequential (arm B) or concurrent trastuzumab (arm C) in the phase III early-stage human epidermal growth fact...
    Buy PDF
  3. Sexual activity and function among middle-aged and older men and women with hypertension.
    Erica S Spatz, Maureen E Canavan, and Stacy T Lindau

    J Hypertens 31(6):1096-1105 (2013) PMID 23640604

    : Among men, comparing treated HTN with untreated HTN and no HTN, sexual activity was less prevalent (66.5 vs. 75.9 vs.71.5%, Pā€Š<0.01) and sexual problems were more prevalent (69.1 vs. 57.7 vs. 54.3%; Pā€Šā‰¤ā€Š0.01). There was no association between treated HTN and sexual activity [odds ratio, OR...
    Buy PDF